The EPS projection of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) for quarter ended 2016-09-30 is $-0.19. A week before, the EPS forecast was $-0.19 against target of $-0.19, a month earlier. This estimate stood at $-0.19 60 days earlier versus forecast of $-0.19 90 days earlier, confirming a deviation of 0%.
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 0.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 2, 3, 0 and 2, respectively.
The downgrade of EPS estimates for ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) in the preceding 120, 60, 30 and 90 days were 0, 0, 1 and 0, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) was $-0.19. This projection was computed after accounting 4 calls. As reported on 2016-05-10 the EPS was $-0.28. The change was $0.01, demonstrating a percentage deviation of 3.45%. The projections confirmed a standard deviation of 0.09.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) stands at $50.827 and the median estimate at $50.827. Almost 2 analysts announced their estimates.
The highest estimate is $57.412 while the lowest target is $44.242 showing standard deviation of 9.312%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 0.001%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) stated that the change in forecast was -1.595%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...